論抗老化及美學之研究動向（二）

Study on Anti-Aging and Aesthetic Research (2)

10.30001/JIES.201109.0010

鄭富元(Fu-Yen Cheng)；侯建維(Jen-We Hou)；許德發(Te-Fa Hsu)；平島愛子(Aiko Hirashima)；江吳佩玲(Pei-Ling Chiangwu)

人工多能性幹細胞 ； 內在美 ； 外在美 ； iPS cell ； inside aesthetic ； outside aesthetic

美容科技學刊

8卷3期（2011 / 09 / 01）

128 - 135

繁體中文

研究論文主要目的，在告知iPS（induced pluripotent Stem）cell，自二○○六年八月京都大學山中伸彌教授由老鼠製作成功以來，引導全球利用iPS細胞在難治疾病及皮膚再生美容醫療方面有飛躍性進展，抗衰老美容之新醫學時代已指日可待。東方黃種人之皮膚老化比白種人及黑種人晚10～20年左右，皮膚老化分成四等級，第一級老化（皺紋、色素斑），第二級老化（動態皺紋、老人斑），第三級老化（靜態皺紋、法令紋），第四級老化（滿臉皺紋、骨質疏鬆白髮）。人類為地球上最追求抗老化長壽的動物。人生要追求內在美化與外在美化，乃希望長生不老及青春永駐。iPS細胞之發明乃是目前人類皮膚及五臟六腑等再生醫療之美化，唯一可期待的美容醫療革命。

Supercritical c The purpose of the research is that study on anti-aging from induced pluripotent stem cell（iPS cell）. The grow old of skin divides into four degrees：① The first degree（wrinkle. freckles） ② The second degree（wrinkle of movement. freckles of senility） ③ The third degree（wrinkle of stationary. Wrinkle of cheek） ④The fourth degree（wrinkle of all face. Osteoporosis. White hair） New research of the clinical study of iPS cell also hopes to inspire much more scholars to develop effective methods without any side-effects for the treat of diseases of anti-aging through inside aesthetic of internal organs to outside aesthetic of skin.

1. Chen, Mark(2013).The Kingdom of Poisonous Matter.yihsient publishing CO, Ltd..
2. Cheng、 Fu-Yen(2011).Aiko Hirashima : Study on anti-aging and aesthetic research(2).The Journal of International Esthetic Science,8(3),128-135.
3. Larren, M.R.(2010).Apixaban versus enoxaparin for thromboprophylaxis aeter hip replacement.New England Journal Medicine,363,2487-98.
4. Larren, M.R.(2010).Apixaban versus enoxaparin for thromboprophylaxis after knee replacement: a randomized double-flind trial.Lancet,375,807-15.
5. Singnal, S.(1999).Antitumor Activity of Thalidomide in Refractory Multiple Myeloma.New England Journal Medicine,341,1565-1571.
6. Uad-Tarazi, F.M.,Okabe, M.(1995).Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension.The American Journal of Medicine,99(6),604-610.
7. Wallentin, L.(2010).Efficacy and rafety of dabigatran compared with warfarin at different levels of international normalized ratio contral for stroke prevention in atrial fibrillation: an analysis of the re-lytrial.Lancet,376,975-983.
8. 平島吉、平島光(2013)。醫療社會學。五南圖書公司。
9. 平島吉、平島光(2013)。醫師失業時代。國際經營健康中心=IMH。